MARKET

ADVM

Adverum Biotech
ADVM
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.6588
90.83
-1.7235
96,257,756.12
*News On Adverum Biotechnologies Inc. (ADVM) Now Under LLY
Dow Jones · 12/09/2025 22:08
Adverum Biotechnologies Completes Merger and Delisting
TipRanks · 12/09/2025 21:38
Eli Lilly completes acquisition of Adverum Biotechnologies
Seeking Alpha · 12/09/2025 14:29
Eli Lilly And Adverum Announce Expiration Of Tender Offer By Lilly Subsidiary To Acquire All Outstanding Adverum Shares For $3.56 Cash Plus Up To $8.91 Per Share In Contingent Value Rights, As Scheduled On December 8
Benzinga · 12/09/2025 13:33
*Eli Lilly: Parties Expect to Consummate the Acquisition on Dec 9 >LLY
Dow Jones · 12/09/2025 13:32
*Lilly and Purchaser Accepted for Payment, and Will Promptly Pay, for All Shrs
Dow Jones · 12/09/2025 13:32
ELI LILLY - ACQUISITION EXPECTED TO CONSUMMATE ON DECEMBER 9, 2025
Reuters · 12/09/2025 13:29
Adverum Biotechnologies CEO Laurent Fischer Reports Acquisition of Common Shares
Reuters · 12/09/2025 02:45
More

Webull offers Adverum Biotech stock information, including NASDAQ: ADVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADVM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADVM stock methods without spending real money on the virtual paper trading platform.